Induction of skin sensitization is augmented in Nrf2-deficient mice

Jochem W van der Veen1, Eric R Gremmer, Jolanda P Vermeulen

  • 1Department of Toxicogenomics, Maastricht University, The Netherlands. Jochem.van.der.Veen@rivm.nl

Archives of Toxicology
|November 13, 2012
PubMed

Insights

Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) plays a key role in mitigating skin sensitization. Nrf2-deficient mice exhibited a heightened response, confirming Nrf2

Area of Science:

  • Immunology
  • Dermatology
  • Toxicology

Background:

  • In vitro studies highlight the role of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) in skin sensitization.
  • The precise in vivo function of the Nrf2-Keap1 pathway in skin sensitization induction is not fully understood.

Purpose of the Study:

  • To elucidate the in vivo role of Nrf2 in the induction of skin sensitization.
  • To investigate the Nrf2-Keap1 pathway's involvement in mitigating immune responses during skin sensitization.

Main Methods:

  • A local lymph node assay was conducted using wild-type and Nrf2-deficient mice.
  • Mice were exposed to 2,4-dinitrochlorobenzene to induce skin sensitization.

Main Results:

  • Nrf2-deficient mice demonstrated a significantly more pronounced sensitization response compared to wild-type mice.
  • These findings indicate that Nrf2 actively suppresses the development of skin sensitization.

Conclusions:

  • The Nrf2-Keap1 pathway is crucial for dampening the induction of skin sensitization in vivo.
  • Targeting the Nrf2 pathway may offer therapeutic strategies for managing allergic contact dermatitis.